PATENT CLAIM ANALYSIS

Application Number: 16229128
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "178100"]

Abstract:
Described herein are methods and compositions relating to anti-Chi3L1 antibodies, antibody reagents, and antigen-binding fragments thereof which display superior properties, e.g., high sensitivity, high specificity, high binding affinity, neutralization activity ex vivo and in vivo (e.g., blocks Chi3L1-induced MAPK and AKT signaling). Methods of treatment, e.g., of treating cancer, obesity, and/or asthma by administering the compounds described herein are also provided.

Claim (Index 28):
The method of  claim 17 , wherein the cancer is malignant cancer.

Metadata:
- Claim Count in Document: 64.0
- Percentile: 98.0
- Lexical Diversity: 1.42593
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16124558', '15507012', '15486468', '15256152', '14914704']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7545746009608804
- 35 USC 102 Novelty (BERT): 0.5808306879430896
- Combined Prediction Score: 0.7372002096591013
- Mean Citation Score: 398.717632
- Max Citation Score: 565.2068
- Similarity Product: 347.82345641736987

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test